Capital Group Private Client Services, Inc. Allogene Therapeutics, Inc. Transaction History

Capital Group Private Client Services, Inc.

  • $9.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$7.65 - $15.29 $1.12 Million - $2.25 Million
-146,877 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$13.13 - $24.52 $371,316 - $693,425
-28,280 Reduced 16.15%
146,877 $2.19 Million
Q3 2021

Nov 15, 2021
BUY
$21.01 - $27.64 $3.68 Million - $4.84 Million
175,157 New
175,157 $4.5 Million

Others Institutions Holding ALLO

# of Institutions
164
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $259M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Capital Group Private Client Services, Inc. Portfolio

Follow Capital Group Private Client Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email